Asthma
COPD
Pulmonary
Pulmonary
What do copper and lung cancer have in common?
A newly developed copper sensing probe could be first step in chelation therapy.
February 7, 2025
Winrevair trial reaches primary endpoints early
Merck ends Hyperion trial of pulmonary arterial hypertension to focus on final analysis.
February 7, 2025
How to train lung disease diagnoses
Artificial intelligence model identifies respiratory disorders with 97% accuracy.
January 30, 2025
Sponsored
Prospects across the asthma market
Ascend Media
The 2024 Asthma Pipeline Insight report provides global coverage of existing and emerging asthma therapies, as well as updates on future growth potential.
October 31, 2024
COVID-19 analysis opens door to future pulmonary fibrosis treatment
Groundbreaking research sheds light on potential strategies to reduce or repair damage from lung disease.
January 30, 2025
European Commission approves new first-line treatment for NSCLC
Lazertinib-amivantamab combination therapy shows success compared to current standard of care.
January 29, 2025
Hyperuricemia could contribute to PAH
Analysis suggests high uric acid levels could be an important risk factor for pulmonary arterial hypertension.
January 29, 2025
Sponsored
CDC immunization plan for 2024–2025
Ascend Media
Review new vaccine guidance to prepare for the fall/winter virus season.
November 7, 2024
Pulse check: Newly proposed FDA guidance
Updated recommendations aim to improve performance of pulse oximeters for all people.
January 17, 2025
Aspartate’s surprising role in driving cancer
Discovery opens door to new therapeutic interventions for lung metastases.
January 17, 2025
New lung scan shows treatment effects in real time
Test could help identify lung function decline sooner.
January 7, 2025
Sponsored
CDC immunization plan for 2024–2025
Ascend Media
Review new vaccine guidance to prepare for the fall/winter virus season.
November 7, 2024
A novel benefit of cough syrup
Common ingredient could help treat lung fibrosis.
January 6, 2025
Deupirfenidone phase 2b trial achievements
The potential IPF therapy successfully slowed the rate of lung function decline compared to placebo and standard-of-care treatment.
January 6, 2025
Potential breakthrough for treating lung cancer
New technology delivers nanomedicines through manufactured gas bubbles.
January 2, 2025
Page 1 of 16
Next Page
Most Popular
COVID-19 analysis opens door to future pulmonary fibrosis treatment
How to train lung disease diagnoses
Prenatal use of asthma biologics receives global consensus
More, less or empty?
Healthy diet, lifestyle can make a difference in managing asthma
Lung volume reduction surgery may help emphysema